Related Experiment Video
Updated: Jul 2, 2026
A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model
Published on: November 25, 2022
Novel suppressors of alpha-synuclein toxicity identified using yeast
Jun Liang1, Cheryl Clark-Dixon, Shaoxiao Wang
1Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, Shreveport, LA 71130-3932, USA.
Abstract:
The mechanism by which the Parkinson's disease-related protein alpha-synuclein (alpha-syn) causes neurodegeneration has not been elucidated. To determine the genes that protect cells from alpha-syn, we used a genetic screen to identify suppressors of the super sensitivity of the yeast Saccharomyces cerevisiae expressing alpha-syn to killing by hydrogen peroxide. Forty genes in ubiquitin-dependent protein catabolism, protein biosynthesis, vesicle trafficking and the response to stress were identified. Five of the forty genes--ENT3, IDP3, JEM1, ARG2 and HSP82--ranked highest in their ability to block alpha-syn-induced reactive oxygen species accumulation, and these five genes were characterized in more detail. The deletion of any of these five genes enhanced the toxicity of alpha-syn as judged by growth defects compared with wild-type cells expressing alpha-syn, which indicates that these genes protect cells from alpha-syn. Strikingly, four of the five genes are specific for alpha-syn in that they fail to protect cells from the toxicity of the two inherited mutants A30P or A53T. This finding suggests that alpha-syn causes toxicity to cells through a different pathway than these two inherited mutants. Lastly, overexpression of Ent3p, which is a clathrin adapter protein involved in protein transport between the Golgi and the vacuole, causes alpha-syn to redistribute from the plasma membrane into cytoplasmic vesicular structures. Our interpretation is that Ent3p mediates the transport of alpha-syn to the vacuole for proteolytic degradation. A similar clathrin adaptor protein, epsinR, exists in humans.
Insights
Researchers identified genes protecting yeast cells from alpha-synuclein (alpha-syn) toxicity. Five key genes, including ENT3, were found to block alpha-syn-induced reactive oxygen species, suggesting protective mechanisms against Parkinson's disease pathology.
Area of Science:
- Cell Biology
- Neuroscience
- Genetics
Background:
- The precise mechanism by which alpha-synuclein (alpha-syn) contributes to neurodegeneration in Parkinson's disease remains unclear.
- Understanding protective factors against alpha-syn toxicity is crucial for developing therapeutic strategies.
Purpose of the Study:
- To identify genes that confer cellular protection against alpha-synuclein-induced toxicity.
- To elucidate the pathways involved in alpha-synuclein-mediated neurodegeneration.
Main Methods:
- A genetic screen was performed in Saccharomyces cerevisiae (yeast) expressing alpha-synuclein.
- The screen identified suppressors of hypersensitivity to hydrogen peroxide-induced killing.
- Key protective genes were further characterized by gene deletion and protein localization studies.
Main Results:
- Forty genes involved in protein catabolism, biosynthesis, vesicle trafficking, and stress response were identified.
- Five genes (ENT3, IDP3, JEM1, ARG2, HSP82) significantly blocked alpha-synuclein-induced reactive oxygen species.
- Deletion of these five genes exacerbated alpha-synuclein toxicity, confirming their protective role.
- Four of the five identified genes specifically protected against wild-type alpha-synuclein, not inherited mutants (A30P, A53T), suggesting distinct toxicity pathways.
- Overexpression of Ent3p, a clathrin adapter protein, promoted alpha-synuclein redistribution to cytoplasmic vesicles, indicating a role in transport for degradation.
Conclusions:
- Specific genes, particularly those involved in protein trafficking like ENT3, play a protective role against alpha-synuclein toxicity.
- Alpha-synuclein may exert toxicity through a pathway distinct from that affected by inherited mutations.
- Ent3p facilitates the transport of alpha-synuclein for vacuolar degradation, offering a potential therapeutic target.
